{
  "insp_id": "INS-0000906192",
  "layout": "c",
  "customer_id": "335594",
  "customer_name": "Joinn Laboratories",
  "customer_addr": "2600 Hilltop Drive, Building C\nRichmond, CA 94806",
  "certificate": "93-R-0594",
  "site_id": "001",
  "site_name": "Joinn Laboratories CA Inc.",
  "insp_type": "ROUTINE INSPECTION",
  "date": "08-NOV-2023",
  "report_date": "01-DEC-2023",
  "citations": [
    {
      "code": "2.31(c)(3)",
      "kind": "",
      "repeat": false,
      "desc": "Institutional Animal Care and Use Committee (IACUC).",
      "narrative": "In the letter to the Institutional Official (IO) regarding the semiannual report of the animal care and use program review\nand facilities inspection dated 7 August 2023, IACUC approval of the letter had not been given prior to delivery of the\ndocument. The Institutional animal care and use committee (IACUC) must prepare reports of its evaluations and submit\nthe reports to the IO of the research facility. The reports shall be reviewed and signed by a majority of the IACUC\nmembers and submitted upon completion of the program review and inspection.\nCorrect by 11/29/2023"
    },
    {
      "code": "2.31(d)(8)",
      "kind": "",
      "repeat": false,
      "desc": "Institutional Animal Care and Use Committee (IACUC).",
      "narrative": "The facility has an umbrella protocol for the evaluation of the pharmacokinetic and pharmacodynamic evaluation of test\nmaterials. Each test material studied has its own separate detailed study protocol followed under the umbrella. It was\nnoted by Inspectors that the study director/principal investigator for the umbrella protocol was different than the study\ndirector/principal investigator for the test material protocol. The AWA and regulations define the principal investigator as a\nsingle individual responsible for the proposal to conduct research and for the design and implementation of research\ninvolving animals. With separate study directors, it is not possible to know who is responsible for the design and\nimplementation of the research. Proposed activities and proposed significant changes in ongoing activities that have been\napproved by the IACUC may be subject to further appropriate review and approval by officials of the research facility.\nHowever, those officials may not approve an activity involving the care and use of animals if it has not been approved by\nthe IACUC.\nCorrect by 12/11/2023"
    },
    {
      "code": "2.33(a)(2)",
      "kind": "",
      "repeat": false,
      "desc": "Attending veterinarian and adequate veterinary care.",
      "narrative": "Several facility documents were noted during inspection that limit the Attending Veterinarian\u2019s authority to treat animals in\ntheir care. The facility\u2019s \u201cStandard Operating Procedure for the Documentation and Response for Laboratory Animal\nHealth Reports and Treatment Plans\u201d describes actions veterinary staff should follow prior to administering treatment,\nincluding to \u201cobtain permission from the SD (study director) and the Veterinarian before administering treatment. This\nrequirement may only be waived for time-critical emergencies and only if the SD is not immediately available. The SD\nmust approve or deny any treatments before implementation.\u201d In addition, one of the facility\u2019s study protocols states that\n\u201ceuthanasia of moribund animals will be authorized by the Study Director or Veterinarian with the concurrence of the\nStudy Director.\u201d The last document is an animal health report form which includes a \u201cReview and Approval of\nAssessment/Plan\u201d portion on the bottom of the form. This section allows the SD to approve or decline the proposed\ntreatment plan, including the time the approval was obtained. An example of this occurred on 9/4/23, where the\nveterinarian recommended euthanasia due to the declining clinical condition of the animal and waited for SD approval to\neuthanize. If the attending Veterinarian cannot make decisions about veterinary care without consent from study directors,\nthis could lead to unnecessary pain and suffering of the animals. Each research facility shall assure that the Attending\nVeterinarian has appropriate authority to ensure the provision of adequate veterinary care and to oversee the adequacy of\nother aspects of animal care and use.\nCorrect by 12/4/2023\nThis inspection and exit interview were conducted with facility representatives.\nAdditional Inspectors:\nKATHARINE FRANK, VETERINARY MEDICAL OFFICER n"
    }
  ],
  "narrative": "2.31(c)(3) \n   \nInstitutional Animal Care and Use Committee (IACUC). \nIn the letter to the Institutional Official (IO) regarding the semiannual report of the animal care and use program review \nand facilities inspection dated 7 August 2023, IACUC approval of the letter had not been given prior to delivery of the \ndocument. The Institutional animal care and use committee (IACUC) must prepare reports of its evaluations and submit \nthe reports to the IO of the research facility. The reports shall be reviewed and signed by a majority of the IACUC \nmembers and submitted upon completion of the program review and inspection. \n \nCorrect by 11/29/2023 \n2.31(d)(8) \n   \nInstitutional Animal Care and Use Committee (IACUC). \nThe facility has an umbrella protocol for the evaluation of the pharmacokinetic and pharmacodynamic evaluation of test \nmaterials. Each test material studied has its own separate detailed study protocol followed under the umbrella. It was \nnoted by Inspectors that the study director/principal investigator for the umbrella protocol was different than the study \ndirector/principal investigator for the test material protocol. The AWA and regulations define the principal investigator as a \nsingle individual responsible for the proposal to conduct research and for the design and implementation of research \ninvolving animals. With separate study directors, it is not possible to know who is responsible for the design and \nimplementation of the research. Proposed activities and proposed significant changes in ongoing activities that have been \napproved by the IACUC may be subject to further appropriate review and approval by officials of the research facility. \nHowever, those officials may not approve an activity involving the care and use of animals if it has not been approved by \nthe IACUC. \n \nCorrect by 12/11/2023 \n2.33(a)(2) \n   \nAttending veterinarian and adequate veterinary care. \nSeveral facility documents were noted during inspection that limit the Attending Veterinarian\u2019s authority to treat animals in \ntheir care. The facility\u2019s \u201cStandard Operating Procedure for the Documentation and Response for Laboratory Animal\n\nHealth Reports and Treatment Plans\u201d describes actions veterinary staff should follow prior to administering treatment, \nincluding to \u201cobtain permission from the SD (study director) and the Veterinarian before administering treatment. This \nrequirement may only be waived for time-critical emergencies and only if the SD is not immediately available. The SD \nmust approve or deny any treatments before implementation.\u201d In addition, one of the facility\u2019s study protocols states that \n\u201ceuthanasia of moribund animals will be authorized by the Study Director or Veterinarian with the concurrence of the \nStudy Director.\u201d The last document is an animal health report form which includes a \u201cReview and Approval of \nAssessment/Plan\u201d portion on the bottom of the form. This section allows the SD to approve or decline the proposed \ntreatment plan, including the time the approval was obtained. An example of this occurred on 9/4/23, where the \nveterinarian recommended euthanasia due to the declining clinical condition of the animal and waited for SD approval to \neuthanize. If the attending Veterinarian cannot make decisions about veterinary care without consent from study directors, \nthis could lead to unnecessary pain and suffering of the animals. Each research facility shall assure that the Attending \nVeterinarian has appropriate authority to ensure the provision of adequate veterinary care and to oversee the adequacy of \nother aspects of animal care and use.  \n \nCorrect by 12/4/2023 \n \nThis inspection and exit interview were conducted with facility representatives. \n \nAdditional Inspectors: \nKATHARINE FRANK, VETERINARY MEDICAL OFFICER n",
  "animals_total": 152,
  "species": [
    {
      "count": 152,
      "scientific": "Macaca fascicularis",
      "common": "CRAB-EATING MACAQUE / CYNOMOLGUS MONKEY"
    }
  ]
}